These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 5973330)

  • 1. [Chronic poisoning with pyridostigmine bromide and behavior of muscle action potential: electromyographic findings in rabbits].
    Rizzoli A
    Boll Soc Ital Biol Sper; 1966 Jun; 42(12):742-6. PubMed ID: 5973330
    [No Abstract]   [Full Text] [Related]  

  • 2. Pyridostigmine toxicity. Electrophysiological study.
    Park KH; Kim DE; Arnold TW; Oh SJ; Bradley R
    Electromyogr Clin Neurophysiol; 1993 Sep; 33(6):323-8. PubMed ID: 8223330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [2 cases of infantile myasthenia].
    Szliwowski HB
    Acta Neurol Psychiatr Belg; 1967 Jun; 67(6):512-9. PubMed ID: 4964210
    [No Abstract]   [Full Text] [Related]  

  • 4. Interrelation between electromyographic and enzymologic findings in skeletal muscles.
    Tsukiyama K; Ueda K
    Electromyography; 1966; 6(1):77. PubMed ID: 6012390
    [No Abstract]   [Full Text] [Related]  

  • 5. [The experimental cortisone-induced myopathy. Electromyographic study].
    Kaeser HE; Wuthrich R
    Rev Neurol (Paris); 1967 Jul; 117(1):163-4. PubMed ID: 6063855
    [No Abstract]   [Full Text] [Related]  

  • 6. An investigation of acetylcholine released in skeletal muscle and protein unbound drug released in blood based on the pyridostigmine bromide (pretreatment drug) sustained-release pellets by microdialysis technique in the rabbit model.
    Huang YT; Cheng CJ; Lai TF; Tsai TR; Tsai TH; Chuo WH; Cham TM
    Neurosci Lett; 2007 Apr; 416(3):302-6. PubMed ID: 17336457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coding for Medication-related Poisoning and Adverse Effects.
    Yu M
    Continuum (Minneap Minn); 2017 Jun; 23(3, Neurology of Systemic Disease):e17-e19. PubMed ID: 28570335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of pipecuronium bromide with pyridostigmine.
    Alisoglu RM; Nagelhout J; Kyff JV; Perov S; Santoro PW; Scarsella J
    CRNA; 1995 Feb; 6(1):43-5. PubMed ID: 7599547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute behavioral toxicity of pyridostigmine or soman in primates.
    Blick DW; Murphy MR; Brown GC; Yochmowitz MG; Fanton JW; Hartgraves SL
    Toxicol Appl Pharmacol; 1994 Jun; 126(2):311-8. PubMed ID: 8209384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nature of the interactions of pyridostigmine with the nicotinic acetylcholine receptor-ionic channel complex. I. Agonist, desensitizing, and binding properties.
    Pascuzzo GJ; Akaike A; Maleque MA; Shaw KP; Aronstam RS; Rickett DL; Albuquerque EX
    Mol Pharmacol; 1984 Jan; 25(1):92-101. PubMed ID: 6323955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of rocuronium-induced neuromuscular blockade by pyridostigmine in patients with Duchenne muscular dystrophy.
    Muenster T; Forst J; Goerlitz P; Schmitt HJ
    Paediatr Anaesth; 2008 Mar; 18(3):251-5. PubMed ID: 18230069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasmapheresis in myasthenia gravis].
    Jauregui WO; Di Gressia C; Herrera ME; Muchnik S
    Medicina (B Aires); 1981; 41(5):511-9. PubMed ID: 7345333
    [No Abstract]   [Full Text] [Related]  

  • 13. [Electromyographic studies of skeletal muscles in patients with primary congestive cardiomyopathy].
    Pyzik Z; Reich J; Horzela T; Goldsztajn M
    Przegl Lek; 1983; 40(8):609-14. PubMed ID: 6665216
    [No Abstract]   [Full Text] [Related]  

  • 14. Pyridostigmine in the treatment of orthostatic intolerance.
    Gales BJ; Gales MA
    Ann Pharmacother; 2007 Feb; 41(2):314-8. PubMed ID: 17284509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent/delayed toxic effects of low-dose sarin and pyridostigmine under physical stress (exercise) in mice.
    Husain K; Somani SM
    Indian J Physiol Pharmacol; 2004 Apr; 48(2):150-64. PubMed ID: 15521554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple vaccine and pyridostigmine interactions: effects on cognition, muscle function and health outcomes in marmosets.
    Stevens D; Scott EA; Bowditch AP; Griffiths GD; Pearce PC
    Pharmacol Biochem Behav; 2006 Jun; 84(2):207-18. PubMed ID: 16806443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D-penicillamine-induced myasthenia gravis in primary biliary cirrhosis.
    Marcus SN; Chadwick D; Walker RJ
    Gastroenterology; 1984 Jan; 86(1):166-8. PubMed ID: 6689658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathomechanics of experimental scoliosis in rabbits as determined by electromyography].
    Tokarowski A
    Chir Narzadow Ruchu Ortop Pol; 1973; 38(1):39-44. PubMed ID: 4694977
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of two pre-exposure treatment regimens in acute organophosphate (paraoxon) poisoning in rats: tiapride vs. pyridostigmine.
    Petroianu GA; Hasan MY; Nurulain SM; Arafat K; Sheen R; Nagelkerke N
    Toxicol Appl Pharmacol; 2007 Mar; 219(2-3):235-40. PubMed ID: 17056080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An unusual primary presentation of myasthenia gravis.
    Cook RJ; McParland H; Escudier M
    Br J Oral Maxillofac Surg; 2008 Sep; 46(6):494-6. PubMed ID: 18299163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.